- Mamilla R Charan Raja,
- Anand Babu Velappan,
- Davidraj Chellappan,
- Joy Debnath,
- Santanu Kar Mahapatra
Eur J Med Chem 2017 Aug 12;139:503-518. Epub 2017 Aug 12.
Department of Biotechnology, School of Chemical and Biotechnology, SASTRA University, Thanjavur, India. Electronic address:
Visceral leishmaniasis (VL) is a life threatening infectious disease caused by Leishmania donovani. It leads to the severe immune suppression in the host defense system. Higher cytotoxicity, rigorous side effects and lower therapeutic indexes (TI) of current antileishmanial drugs have created a necessity to develop new molecules with better antileishmanial activity and high TI value. Read More